Verastem (VSTM) Income from Continuing Operations (2011 - 2026)

Verastem (VSTM) recorded quarterly Income from Continuing Operations of 43982000.0 in Q1 2026, down 151.53% quarter-over-quarter from 85354000.0 in Q4 2025, and down 1.33% on a YoY basis from 44573492.69 in Q1 2025.

Verastem (VSTM) Income from Continuing Operations (2011 - 2026) Analysis & Trends

Verastem's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 43982000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations fell 1.33% year-over-year to 43982000.0; the TTM figure through Mar 2026 stood at 41522000.0 (up 68.34% YoY), while the FY2025 annual figure was 209471000.0, down 60.33% from the prior year.
  • Income from Continuing Operations was 43982000.0 for Q1 2026 at Verastem, down from 85354000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 85354000.0 in Q4 2025 to a low of 43982000.0 in Q1 2026.
  • Historically, Income from Continuing Operations has averaged 21433235.29 across 5 years, with a median of 21958000.0 in 2022.
  • Biggest YoY gain for Income from Continuing Operations was 367.0% in 2025; the steepest drop was 133.52% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 16801000.0 in 2022, then tumbled by 80.88% to 30390000.0 in 2023, then retreated by 5.19% to 31968000.0 in 2024, then jumped by 367.0% to 85354000.0 in 2025, then plunged by 151.53% to 43982000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 43982000.0 (Q1 2026), 85354000.0 (Q4 2025), and 39852000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn -43.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -43.98 Mn
Dec 31, 2025 85.35 Mn
Sep 30, 2025 -39.85 Mn
Jun 30, 2025 -43.04 Mn
Mar 31, 2025 -43.41 Mn
Dec 31, 2024 -31.97 Mn
Sep 30, 2024 -37.35 Mn
Jun 30, 2024 -18.43 Mn
Mar 31, 2024 -27.82 Mn
Dec 31, 2023 -30.39 Mn
Sep 30, 2023 -20.19 Mn
Jun 30, 2023 -20.29 Mn
Mar 31, 2023 -19.14 Mn
Dec 31, 2022 -16.80 Mn
Sep 30, 2022 -18.11 Mn
Jun 30, 2022 -21.96 Mn
Mar 31, 2022 -16.99 Mn
Dec 31, 2021 -16.48 Mn
Sep 30, 2021 -22.79 Mn
Jun 30, 2021 -16.90 Mn